Disulfide Bridging Strategies in Viral and Nonviral Platforms for Nucleic Acid Delivery. 2021

Kingshuk Dutta, and Ritam Das, and Jewel Medeiros, and S Thayumanavan

Self-assembled nanostructures that are sensitive to environmental stimuli are promising nanomaterials for drug delivery. In this class, disulfide-containing redox-sensitive strategies have gained enormous attention because of their wide applicability and simplicity of nanoparticle design. In the context of nucleic acid delivery, numerous disulfide-based materials have been designed by relying on covalent or noncovalent interactions. In this review, we highlight major advances in the design of disulfide-containing materials for nucleic acid encapsulation, including covalent nucleic acid conjugates, viral vectors or virus-like particles, dendrimers, peptides, polymers, lipids, hydrogels, inorganic nanoparticles, and nucleic acid nanostructures. Our discussion will focus on the context of the design of materials and their impact on addressing the current shortcomings in the intracellular delivery of nucleic acids.

UI MeSH Term Description Entries
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D012313 RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) RNA, Non-Polyadenylated,Ribonucleic Acid,Gene Products, RNA,Non-Polyadenylated RNA,Acid, Ribonucleic,Non Polyadenylated RNA,RNA Gene Products,RNA, Non Polyadenylated
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Kingshuk Dutta, and Ritam Das, and Jewel Medeiros, and S Thayumanavan
January 2012, Current medicinal chemistry,
Kingshuk Dutta, and Ritam Das, and Jewel Medeiros, and S Thayumanavan
January 2010, Topics in current chemistry,
Kingshuk Dutta, and Ritam Das, and Jewel Medeiros, and S Thayumanavan
April 2011, Therapeutic delivery,
Kingshuk Dutta, and Ritam Das, and Jewel Medeiros, and S Thayumanavan
January 2012, Advanced biomedical research,
Kingshuk Dutta, and Ritam Das, and Jewel Medeiros, and S Thayumanavan
January 2016, Frontiers in molecular neuroscience,
Kingshuk Dutta, and Ritam Das, and Jewel Medeiros, and S Thayumanavan
May 2013, Journal of controlled release : official journal of the Controlled Release Society,
Kingshuk Dutta, and Ritam Das, and Jewel Medeiros, and S Thayumanavan
April 2012, Nanomedicine (London, England),
Kingshuk Dutta, and Ritam Das, and Jewel Medeiros, and S Thayumanavan
May 2008, Pharmaceutical research,
Kingshuk Dutta, and Ritam Das, and Jewel Medeiros, and S Thayumanavan
January 2017, Expert opinion on biological therapy,
Kingshuk Dutta, and Ritam Das, and Jewel Medeiros, and S Thayumanavan
July 2020, Journal of controlled release : official journal of the Controlled Release Society,
Copied contents to your clipboard!